Omv AG OMV ORD SHS/ AT0000743059 /
2024-08-02 9:52:23 AM | Chg. -0.22 | Volume | Bid2024-08-02 | Ask2024-08-02 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
38.34EUR | -0.57% | 96 Turnover: 3,669.20 |
37.46Bid Size: 1,500 | 39.04Ask Size: 1,500 | 12.48 bill.EUR | 13.23% | 8.42 |
GlobeNewswire
03-26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
01-16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
2023-09-14
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
2021-10-13
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center